Location effects of vanadium in NiFe layered double hydroxides for oxygen evolution reaction
Journal of Materials Chemistry A · 2024 · 12 (35) · 23447-23453
DOI: 10.1039/d4ta03436h ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry A, 2024. Verfasst von Mengze Ma und 7 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
V can exist as three vanadium-based species, i.e. , doped V III in LDHs laminates, intercalated VO 3 − between LDHs interlayers, and free VO 3 − as an additive in KOH electrolyte. The study shows their role in altering the OER performance of NiFe-LDHs.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Shenzhen Science and Technology Innovation Program
- China Association for Science and Technology
Zitieren
APA
Ma, M., Zhang, Y., Ding, X., Jing, J., Jin, L., Liu, W., Zhou, D., & Sun, X. (2024). Location effects of vanadium in NiFe layered double hydroxides for oxygen evolution reaction. Journal of Materials Chemistry A, 12(35), 23447-23453. https://doi.org/10.1039/d4ta03436h
Vancouver
Ma M, Zhang Y, Ding X, Jing J, Jin L, Liu W, et al. Location effects of vanadium in NiFe layered double hydroxides for oxygen evolution reaction. Journal of Materials Chemistry A. 2024;12(35):23447-23453. doi:10.1039/d4ta03436h
BibTeX
@article{Ma2024,
author = {Ma, Mengze and Zhang, Yechi and Ding, Xiaoqian and Jing, Jianlei and Jin, Linbo and Liu, Wei and Zhou, Daojin and Sun, Xiaoming},
title = {Location effects of vanadium in NiFe layered double hydroxides for oxygen evolution reaction},
journal = {Journal of Materials Chemistry A},
year = {2024},
volume = {12},
number = {35},
pages = {23447--23453},
doi = {10.1039/d4ta03436h}
}
EUVIMED